These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29797640)

  • 1. DIVERGT screening procedure predicts general cognitive functioning in adult long-term survivors of pediatric acute lymphoblastic leukemia: A PETALE study.
    Boulet-Craig A; Robaey P; Laniel J; Bertout L; Drouin S; Krajinovic M; Laverdière C; Sinnett D; Sultan S; Lippé S
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27259. PubMed ID: 29797640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
    Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
    Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric acute lymphoblastic leukemia: redefining outcomes.
    Kadan-Lottick N; Neglia JP
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):88. PubMed ID: 11990711
    [No Abstract]   [Full Text] [Related]  

  • 5. More good news about neuropsychological late effects in long-term survivors of acute lymphoblastic leukemia.
    Waber DP
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):86-7. PubMed ID: 11990710
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.
    Edelstein K; D'agostino N; Bernstein LJ; Nathan PC; Greenberg ML; Hodgson DC; Millar BA; Laperriere N; Spiegler BJ
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):450-8. PubMed ID: 21646917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia.
    Raymond-Speden E; Tripp G; Lawrence B; Holdaway D
    J Pediatr Psychol; 2000 Mar; 25(2):59-68. PubMed ID: 10820944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
    Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
    Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
    Kunin-Batson A; Kadan-Lottick N; Neglia JP
    Psychooncology; 2014 Jun; 23(6):692-9. PubMed ID: 24497266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate.
    Zając-Spychała O; Pawlak M; Karmelita-Katulska K; Pilarczyk J; Jończyk-Potoczna K; Przepióra A; Derwich K; Wachowiak J
    Leuk Lymphoma; 2018 Oct; 59(10):2342-2351. PubMed ID: 29424258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term psychological effects of childhood leukemia and its treatment.
    Jannoun L; Chessells JM
    Pediatr Hematol Oncol; 1987; 4(4):293-308. PubMed ID: 2484651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computerized psychometry screening in long-term survivors of childhood acute lymphoblastic leukemia.
    O'Hare AE; Aitken K; Eden OB
    Pediatr Hematol Oncol; 1988; 5(3):197-208. PubMed ID: 3152965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
    Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
    Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
    Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
    Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
    Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
    Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity.
    Waber DP; Silverman LB; Catania L; Mautz W; Rue M; Gelber RD; Levy DE; Goldwasser MA; Adams H; Dufresne A; Metzger V; Romero I; Tarbell NJ; Dalton VK; Sallan SE
    J Clin Oncol; 2004 Jul; 22(13):2701-7. PubMed ID: 15226337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Fatigue to Cognitive Dysfunction in Childhood Acute Lymphoblastic Leukemia Survivors.
    Mochon A; Lippé S; Krajinovic M; Laverdière C; Marjerrison S; Michon B; Robaey P; Rondeau É; Sinnett D; Sultan S
    Pediatr Hematol Oncol; 2023; 40(6):554-567. PubMed ID: 37469296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.